79 related articles for article (PubMed ID: 38589525)
1. LATS2 condensates organize signalosomes for Hippo pathway signal transduction.
Qin M; Geng E; Wang J; Yu M; Dong T; Li S; Zhang X; Lin J; Shi M; Li J; Zhang H; Chen L; Cao X; Huang L; Wang M; Li Y; Yang XP; Zhao B; Sun S
Nat Chem Biol; 2024 Jun; 20(6):710-720. PubMed ID: 38200110
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.
Wang Y; Xu X; Maglic D; Dill MT; Mojumdar K; Ng PK; Jeong KJ; Tsang YH; Moreno D; Bhavana VH; Peng X; Ge Z; Chen H; Li J; Chen Z; Zhang H; Han L; Du D; Creighton CJ; Mills GB; ; Camargo F; Liang H
Cell Rep; 2018 Oct; 25(5):1304-1317.e5. PubMed ID: 30380420
[TBL] [Abstract][Full Text] [Related]
3. Mapping the STK4/Hippo signaling network in prostate cancer cell.
Ready D; Yagiz K; Amin P; Yildiz Y; Funari V; Bozdag S; Cinar B
PLoS One; 2017; 12(9):e0184590. PubMed ID: 28880957
[TBL] [Abstract][Full Text] [Related]
4. Zinc finger protein 367 exerts a cancer-promoting role in small cell lung cancer by influencing the CIT/LATS2/YAP signaling cascade.
Kong R; Ma Y; Li W; Xu Z; Gong S; Liu A; Cheng C; Zhang X; Qin J; Li S; Feng J; Jiang J
Toxicol Appl Pharmacol; 2024 Jun; ():117005. PubMed ID: 38880190
[TBL] [Abstract][Full Text] [Related]
5. Reactivating Hippo by drug compounds to suppress gastric cancer and enhance chemotherapy sensitivity.
Cao Z; Hou Y; Zhao Z; Zhang H; Tian L; Zhang Y; Dong C; Guo F; Tan L; Han Y; Wang W; Jiao S; Tang Y; An L; Zhou Z
J Biol Chem; 2024 Apr; 300(6):107311. PubMed ID: 38657866
[TBL] [Abstract][Full Text] [Related]
6. The interplay between non-coding RNAs and Twist1 signaling contribute to human disorders.
Ghafouri-Fard S; Abak A; Bahroudi Z; Shoorei H; Abbas Raza SH; Taheri M
Biomed Pharmacother; 2021 Mar; 135():111220. PubMed ID: 33433357
[TBL] [Abstract][Full Text] [Related]
7. The possible correlation between miR-762, Hippo signaling pathway, TWIST1, and SMAD3 in lung cancer and chronic inflammatory diseases.
Hussein NA; Ebid SA; Ahmad MA; Khedr GE; Saad DM
Sci Rep; 2024 Apr; 14(1):8246. PubMed ID: 38589525
[TBL] [Abstract][Full Text] [Related]
8. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
10. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
[TBL] [Abstract][Full Text] [Related]
11. Expression of hippo pathway in colorectal cancer.
Liang K; Zhou G; Zhang Q; Li J; Zhang C
Saudi J Gastroenterol; 2014; 20(3):188-94. PubMed ID: 24976283
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2.
Song L; Huang Y; Zhang X; Han S; Hou M; Li H
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):32. PubMed ID: 32186675
[TBL] [Abstract][Full Text] [Related]
13. MiR-762 regulates the activation of PI3K/AKT and Hippo pathways involved in the development of gastric cancer by targeting LZTS1.
Yu K; Zhu H
Am J Transl Res; 2022; 14(7):5050-5058. PubMed ID: 35958482
[TBL] [Abstract][Full Text] [Related]
14. RAB26 contributes to the progression of non-small cell lung cancer after being transcriptionally activated by SMAD3.
Ren H; Yang B; Li M; Lu C; Li X
Bioengineered; 2022 Apr; 13(4):8064-8075. PubMed ID: 35291909
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
